These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16894432)
21. Identifying patients for aggressive cholesterol lowering: the risk curve concept. Robinson JG; Stone NJ Am J Cardiol; 2006 Nov; 98(10):1405-8. PubMed ID: 17134640 [TBL] [Abstract][Full Text] [Related]
22. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]
23. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508 [TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms and statin therapy. Zineh I JAMA; 2004 Sep; 292(11):1302-3. PubMed ID: 15367547 [No Abstract] [Full Text] [Related]
25. Intensive lipid lowering with atorvastatin in coronary disease. Modest GA N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003833 [No Abstract] [Full Text] [Related]
26. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). HMG-CoA reductase inhibitors: a review of published clinical trials and pharmacoeconomic evaluations. Int J Technol Assess Health Care; 1998; 14(2):396-8. PubMed ID: 9678976 [No Abstract] [Full Text] [Related]
28. High marks for below-average cholesterol. For the best protection against clogged arteries and heart disease, average cholesterol no longer makes the grade--lower is better. Harv Heart Lett; 2006 Feb; 16(6):4-5. PubMed ID: 19662696 [No Abstract] [Full Text] [Related]
29. Navigating patient preference and guidelines as a fellow. Gosain P J Am Coll Cardiol; 2015 Feb; 65(4):398-400. PubMed ID: 25634841 [No Abstract] [Full Text] [Related]
30. Intensive cholesterol lowering: no longer a myth. Bitzur R; Harats D Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708 [No Abstract] [Full Text] [Related]
31. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
33. Response: “Actually, it’s more of a guideline than a rule”. Halperin JL J Am Coll Cardiol; 2015 Feb; 65(4):400. PubMed ID: 25793247 [No Abstract] [Full Text] [Related]
34. Statins: some women don't get the benefits. Consum Rep; 2010 Aug; 75(8):12. PubMed ID: 20648735 [No Abstract] [Full Text] [Related]
36. Is myopathy the Achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice. Rallidis LS; Anastasiou-Nana M J Am Coll Cardiol; 2014 Jun; 63(21):2300-1. PubMed ID: 24613338 [No Abstract] [Full Text] [Related]
37. [About: pleiotropic effects of statins in atherosclerosis]. Ambrosi P Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1263; author reply 1263-5. PubMed ID: 16435610 [No Abstract] [Full Text] [Related]
38. Reply: is myopathy the achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice. American College of Cardiology J Am Coll Cardiol; 2014 Jun; 63(21):2301. PubMed ID: 24613340 [No Abstract] [Full Text] [Related]
39. Statin therapy: more than meets the eye? McCain J Manag Care; 2004 Apr; 13(4):40-9. PubMed ID: 15146720 [No Abstract] [Full Text] [Related]
40. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]